Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Herpes Article
This is a selection made from among articles on Drug Treatment Herpes. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Addiction Treatment: When One More Drug Is Too Many
from:by Judy Wellsworth
Drug addiction treatment has only one goal: to help addicts attain a life free of drug use. It achieves this goal in a variety of ways, but all of them are focused on helping addicts modify their existing destructive behaviors into healthier ones.Many drug addiction treatment centers regard the uses of drugs in treatment to be counterproductive; so their patients must detoxify without assistance from either sedatives or pain relievers. The one obvious, if uncomfortable, benefit to this approach is that the recovering addict will remember the pain of withdrawal and perhaps be dissuaded from returning to drug abuse.Relapse PreventionRelapse prevention is a form of drug addiction treatment in which the addicts are taught self-control. Exposed to the kinds of situations in which they would previously have succumbed to their drug cravings, they learn ways to anticipate and avoid the situations. Becoming skilled at this type of avoidance will be one way addicts can deal with temptation away from the security of the treatment facility.Studies have shown that those skills stay with recovering addicts who completed their relapse prevention treatment. One research study indicated that the majority of the addicts on whom follow-up information was gathered were successfully avoiding dangerous situations all through the year following their treatment.Supportive-Expressive TreatmentSupportive-expressive psychotherapy is a drug addiction treatment found to be effective with heroin and cocaine abusers. It requires the addicts to learn interpersonal skills, developing their abilities to trust others and to look for support when struggling with their addictions. The Matrix ModelThe third drug addiction treatment is the matrix model, in extremely in-depth treatment in which the addict receives very close direction from a therapist, learns about available self-help options, and undergoes regular urine testing. The Matrix Model even includes an addict’s family in the recovery process.Outpatient Drug-Free Treatment is an option for those who cannot afford residential or treatment, and is often the only choice for addicts who have jobs. Some outpatient drug addiction treatment can offer the intensive therapies discussed above if the addicts’ conditions require them. Others are not much more than substance abuse awareness programs. Group counseling is the focus of many outpatient drug addiction treatments. There are a large number of drug addictions treatments available to those seeking recovery. In addition to the drug-free ones mentioned, many treatments employ methadone or sedatives to take the edge off the withdrawal process. But for those addicts whose physical conditions will simply not tolerate anymore drugs, drug-free addiction treatment is the ideal answer.
You can also find more info on Drug Addiction Programs and Drug Addiction Recovery. Drugtreatmentinfo.org is a comprehensive resource to known more about drug addiction.
Drug Treatment Herpes Specific links
Drug Treatment Herpes News
Clinigen gains US FDA approval for Foscavir in HIV/AIDS-related ... - MarketWatch (press release)
Clinigen gains US FDA approval for Foscavir in HIV/AIDS-related ... MarketWatch (press release) Clinigen Healthcare, the pharmaceutical products division of Clinigen Group, announced today that its supplemental new drug application (sNDA) for Foscavir (foscarnet sodium), a treatment for HIV/AIDS-related cytomegalovirus (CMV) infections and herpes ... |
FDA Approves Foscarnet for HIV-Related CMV Retinitis, Herpes - Medscape
FDA Approves Foscarnet for HIV-Related CMV Retinitis, Herpes Medscape May 10, 2012 — The US Food and Drug Administration (FDA) has approved foscarnet sodium injection (Foscavir, Clinigen) for the treatment of HIV/AIDS-related cytomegalovirus (CMV) infections and herpes. Foscarnet sodium is now indicated for the ... FDA approves Clinigen sNDA for Foscavir |
NanoViricides Announces Issuance of a Fundamental Patent in the USA - OneMedPlace (blog)
 OneMedPlace (blog) | NanoViricides Announces Issuance of a Fundamental Patent in the USA OneMedPlace (blog) NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack enveloped virus particles and to ... |
NanoViricides Announces Issuance of a Fundamental Patent in the USA - MarketWatch (press release)
 Proactive Investors USA & Canada | NanoViricides Announces Issuance of a Fundamental Patent in the USA MarketWatch (press release) 8173764) is granted for "Solubilization and Targeted Delivery of Drugs with Self-Assembling Amphiphilic Polymers." It will be issued on May 8, 2012. The patent term is expected to last through October 1, 2026, including an anticipated extension, ... NanoViricides' antiviral lands US patent |
NanoViricides Appoints Mr. Andrew Hahn as Consultant for Design and ... - MarketWatch (press release)
NanoViricides Appoints Mr. Andrew Hahn as Consultant for Design and ... MarketWatch (press release) In addition to influenza, the Company has several additional drugs in its development pipeline. These include eye drops for viral infections of the external eye (such as EKC and Ocular Herpes), skin cream for treatment of oral and genital warts (caused ... |
Beware of ARV, TB Drugs Side Effects - AllAfrica.com
Beware of ARV, TB Drugs Side Effects AllAfrica.com ... TB, herpes, pneumonia, among a host of other illnesses. Before the immune system was compromised one had the potential to stave off a cold even without taking medication, but with HIV playing havoc on the system, a simple cold cannot be treated by ... |
Vical's CEO Presents at Bank of America Merrill Lynch Health Care Conference ... - Seeking Alpha
Vical's CEO Presents at Bank of America Merrill Lynch Health Care Conference ... Seeking Alpha Allovectin is the lead program, we have a substantial franchise for treating CMV disease we have partnered that with Astellas. And then we have an exciting preclinical program for Herpes Simplex 2, where nothing is really going on, but one out of three ... |
First Ever National Science, Technology and Innovation Week Wows - The Star
First Ever National Science, Technology and Innovation Week Wows The Star “This drug is a milestone discovery that will completely change the treatment regiment for the dreaded herpes virus, which is one of the opportunistic infections in HIV/Aids”, he said. The drug is cheap, and has shown remarkable results particularly ... |
NanoViricides Announces Issuance of a Fundamental Patent in the USA - OneMedPlace (blog)
OneMedPlace (blog) | NanoViricides Announces Issuance of a Fundamental Patent in the USA OneMedPlace (blog) The company is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, ... |
Virus linked to macular degeneration - Science a Gogo
 Science a Gogo | Virus linked to macular degeneration Science a Gogo by Will Parker US scientists have found that a type of herpes-virus infection of the eye is associated with age-related macular degeneration, a disease that causes blindness in the elderly. The findings, appearing in PLoS Pathogens, indicate that human ... |